semaglutide vs metformin PDF] Efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised oral semaglutide vs metformin Rybelsus
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
![semaglutide vs metformin PDF] Efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised oral semaglutide vs metformin Rybelsus](https://images.ctfassets.net/4f3rgqwzdznj/6GB7ECTirc4sY4JOmHvpjP/ccad39c620cd3e4f110e0321f18cea07/drug_interaction_metformin.png)
![semaglutide vs metformin PDF] Efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised oral semaglutide vs metformin Rybelsus](https://plexusdx.com/cdn/shop/articles/p11_4b44e676-758a-4245-ab72-5a5161366323.jpg?v=1780633418&width=4608)
![semaglutide vs metformin PDF] Efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised oral semaglutide vs metformin Rybelsus](https://www.singlecare.com/blog/wp-content/uploads/2024/08/wegovy-vs-metformin-300x169.png)
![semaglutide vs metformin PDF] Efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised oral semaglutide vs metformin Rybelsus](https://marley-files.imgix.net/0e8aa07b-ae1a-4133-8285-dbe9f8269dab/MetforminvsOzempic.jpg?fm=webp)
![semaglutide vs metformin PDF] Efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised oral semaglutide vs metformin Rybelsus](https://images.ctfassets.net/yixw23k2v6vo/6b0RdYw0V9uPqXnrkA7cW/c870059af8cd74bae63f3d65b9e875f2/GettyImages-2171172433-3000x2000.jpg)



















